Private Advisor Group LLC lowered its position in The Clorox Company (NYSE:CLX – Free Report) by 5.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 32,991 shares of the company’s stock after selling 1,859 shares during the period. Private Advisor Group LLC’s holdings in Clorox were worth $5,051,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Fortitude Family Office LLC acquired a new stake in Clorox in the 4th quarter worth approximately $29,000. Venturi Wealth Management LLC lifted its stake in Clorox by 308.5% during the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after acquiring an additional 145 shares during the period. Northwest Financial Advisors acquired a new stake in Clorox during the 4th quarter valued at approximately $29,000. Core Wealth Advisors Inc. acquired a new stake in Clorox during the 4th quarter valued at approximately $29,000. Finally, First United Bank & Trust acquired a new stake in Clorox during the 4th quarter valued at approximately $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Trading Up 0.6 %
Shares of CLX stock traded up $0.76 on Friday, hitting $133.22. 1,029,185 shares of the stock traded hands, compared to its average volume of 1,179,589. The firm’s 50-day moving average price is $135.62 and its two-hundred day moving average price is $143.45. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The stock has a market capitalization of $16.54 billion, a PE ratio of 69.02, a PEG ratio of 1.97 and a beta of 0.39. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14.
Analysts Set New Price Targets
Several brokerages have commented on CLX. Wells Fargo & Company decreased their price objective on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a research note on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. Evercore ISI decreased their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. Argus upgraded shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. Five investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $145.33.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 7/1 – 7/5
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- Pros And Cons Of Monthly Dividend Stocks
- Qualcomm Stock Continues to Rise in the Face of Negative News
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.